Cue

Escalade Reports Second Quarter 2021 Results

Retrieved on: 
목요일, 8월 5, 2021
Company, Chief executive officer, U.S. Securities and Exchange Commission, Pressure, Investor relations, Earnings before interest, taxes, depreciation and amortization, Lists of disasters, Technology, Information, Escalade Sports, COVID-19, RAVE, Archery, X-ray photoelectron spectroscopy, Sport, Sale, Cue, Tennis, Income, Interim, Compliance, SG, Sporting Goods, Habit, Nasdaq, Security (finance), Corporation, GLOBE, Healthcare, Ridesharing company, Warehouse, Risk management

EVANSVILLE, Ind., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Escalade, Incorporated (NASDAQ: ESCA) – today announced its second quarter results for 2021, ended July 10, 2021. The Company posted quarterly revenue of $99.7 million, an increase of 19.3% over prior year, posting another record for its second fiscal quarter. Quarterly diluted earnings per share were $0.58.

Key Points: 
  • Operating income of $10.7 million vs. $10.9 million in the second quarter of 2020
    EVANSVILLE, Ind., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Escalade, Incorporated (NASDAQ: ESCA) today announced its second quarter results for 2021, ended July 10, 2021.
  • Second quarter results reflect strong demand for our products, offset by sharply higher raw material costs, increased wage pressure, and inventory handling costs.
  • Net sales for the second quarter of 2021 were $99.7 million compared to net sales of $83.5 million for the same quarter in 2020, an increase of $16.2 million or 19.3%.
  • Gross profit for the second quarter of 2021 was $25.1 million compared to gross profit of $23.2 million for the same quarter in 2020.

Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth

Retrieved on: 
목요일, 5월 13, 2021
Food and Drug Administration, United States Public Health Service, Cue

b'SAN DIEGO, May 13, 2021 /PRNewswire/ -- Cue Health Inc. ("Cue Health" or "Cue"), a health technology company, today announced the closing of a $235 million private financing round.

Key Points: 
  • b'SAN DIEGO, May 13, 2021 /PRNewswire/ -- Cue Health Inc. ("Cue Health" or "Cue"), a health technology company, today announced the closing of a $235 million private financing round.
  • At the center of this is the Cue Health Monitoring System, which, together with the Cue COVID-19 Test Kit, was the first-ever FDA authorized molecular-based diagnostic test for over-the-counter and home use.
  • Cue enables people to manage their health through real-time, actionable and connected health data.
  • 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/cue-health-announces-completion-...\n'

Cue Health Launches 'Cue for Schools,' an On-Site Molecular Testing Solution for K-12 and Universities

Retrieved on: 
월요일, 4월 5, 2021
Cue

Cue has also loaned hundreds of mobile smart devices to schools to support their testing programs.

Key Points: 
  • Cue has also loaned hundreds of mobile smart devices to schools to support their testing programs.
  • The Cue Health Monitoring System works with the Cue Test Cartridge, the Cue Sample Wand, and the Cue Health App to convert test samples into accurate digital results.
  • The reusable, battery-operated Cue Cartridge Reader runs the Cue Test Cartridge and communicates results directly to the Cue Health App in about 20 minutes via a mobile smart device.
  • Cue is a health technology company focused on empowering people to live their best and healthiest lives by making their health data accessible and actionable.

Cue Health Expands Leadership Team with Key Executive Appointments

Retrieved on: 
수요일, 3월 24, 2021
Cue

("Cue"), a healthcare technology company, today announced three leadership additions to its executive management team.

Key Points: 
  • ("Cue"), a healthcare technology company, today announced three leadership additions to its executive management team.
  • The addition of John, Erica and Dena to our leadership team strengthens our ability to do just that."
  • The Cue Health Monitoring system works with the Cue Test Cartridge, the Cue Sample Wand, and the Cue Health App to convert test samples into accurate digital results.
  • The reusable, battery-operated Cue Cartridge Reader runs the Cue Test Cartridge and communicates results directly to the Cue Health App in about 20 minutes via a mobile smart device.

Cue Health Named one of Fierce Medtech's "Fierce 15" Companies of 2020

Retrieved on: 
월요일, 3월 8, 2021
Cue, Zimmer Biomet Robotics

(Cue), a leading healthcare technology company, today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry.

Key Points: 
  • (Cue), a leading healthcare technology company, today announced that it has been named by Fierce Medtech as one of 2020's Fierce 15, designating it as one of the most promising private companies in the industry.
  • The Cue OTC Test is authorized for use by symptomatic and asymptomatic individuals, adults and children ages 2 and older with adult assistance.
  • "We are honored to be recognized as one of the 'Fierce 15' for our work," said Clint Sever, Co-Founder and Chief Product Officer of Cue.
  • The Fierce 15 celebrates the spirit of being "fierce" championing innovation and creativity, even in the face of intense competition.

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use

Retrieved on: 
금요일, 3월 5, 2021
Cue stick, COVID-19 testing, Cue

The Cue COVID-19 Test for Home and Over The Counter (OTC) Use (Cue OTC Test) uses a lower nasal swab and delivers results in about 20 minutes to the user's mobile smart device.

Key Points: 
  • The Cue COVID-19 Test for Home and Over The Counter (OTC) Use (Cue OTC Test) uses a lower nasal swab and delivers results in about 20 minutes to the user's mobile smart device.
  • With an easy-to-use, fully guided experience, the Cue OTC Test offers convenience, privacy, safety, and the ability to test frequently, with the accuracy of a centralized lab test.
  • Each Cue OTC Test Cartridge Pack includes the single-use, self-contained Cue Test Cartridge and the Cue Sample Wand, which is the swab for minimally invasive sample collection.
  • The Cue Health Monitoring system works with the Cue Test Cartridge, the Cue Sample Wand, and the Cue Health App to convert test samples into accurate digital results.

APM Music Partners With Qwire to Improve Cue Sheet Reporting

Retrieved on: 
목요일, 11월 19, 2020
Intellectual property law, Cue, APM Music, Royalty payment, Data, Articles, Music

"Everyone benefits from better cue sheet reporting and more access to music" says Scott Freiman, CEO of Qwire.

Key Points: 
  • "Everyone benefits from better cue sheet reporting and more access to music" says Scott Freiman, CEO of Qwire.
  • Per the agreement, APM Music will license Qwire's software to offer their clients advanced technology for cue sheet reporting.
  • Using Qwire's cue sheet reporting software, APM Music's clients will improve their ability to file timely and accurate cue sheets, helping ensure that music royalties are paid correctly.
  • "Everyone benefits from better cue sheet reporting and more access to music," says Scott Freiman, co-founder, and CEO of Qwire.

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Retrieved on: 
금요일, 6월 12, 2020
Cue, Food and Drug Administration, Health, Articles

The system performs rapid molecular analysis at the point-of-care and transmits test results to the Cue Health App on a connected mobile device.

Key Points: 
  • The system performs rapid molecular analysis at the point-of-care and transmits test results to the Cue Health App on a connected mobile device.
  • The current FDA EUA allows the Cue COVID-19 test to be used anywhere under the supervision of qualified medical personnel.
  • We are very pleased to have received FDA EUA for our Cue Health COVID-19 Test.
  • In addition to its COVID-19 test, Cue is developing additional test cartridges for use with the Cue Health Monitoring System, including tests for Influenza A/B.

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Retrieved on: 
수요일, 6월 10, 2020
Cue

SAN DIEGO, June 10, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue), a healthcare technology company, announced today the close of its Series C financing round, raising $100 million in new capital.

Key Points: 
  • SAN DIEGO, June 10, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue), a healthcare technology company, announced today the close of its Series C financing round, raising $100 million in new capital.
  • Investors in Cues Series C include Menlo Park-based Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation - JJDC, Inc., ACME Capital and other investment firms.
  • Proceeds from the financing will be used to complete development, validation, and scale-up of manufacturing of the Cue Health Monitoring System and Cue Test Cartridges.
  • Cues first product under development, the Cue Health Monitoring System, is a connected diagnostic platform.

Cue Health Inc, Product Pipeline Analysis, 2019 Update - Analysis, Key Developments & Key Competitors - ResearchAndMarkets.com

Retrieved on: 
금요일, 1월 24, 2020
Biotechnology, Health, Clinical trials, Health, Articles, Medical diagnosis, Medical terminology, Nosology, Health care, Cue

The "Cue Health Inc - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cue Health Inc - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.
  • Cue Health Inc (Cue Health) operates as a healthcare technology company that strives to design, develop, manufacture and commercialize medical diagnostic products for use in home and clinical settings.
  • The company's lead product, Cue Health Monitoring System, is a connected diagnostic platform that helps in testing clinical samples in a disposable test cartridge and delivering results to a mobile device.
  • Its product finds application in the detection, diagnosis and management of women's health, infectious diseases, cardiovascular health, wellness, and other diseases.